336 related articles for article (PubMed ID: 32682360)
1. Hydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data.
Tanriverdİ E; Çörtük M; Yildirim BZ; Uğur Chousein EG; Turan D; Çinarka H; Özgül MA; Çetinkaya E
Turk J Med Sci; 2021 Feb; 51(1):10-5. PubMed ID: 32682360
[TBL] [Abstract][Full Text] [Related]
2. Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU.
Çalık Başaran N; Uyaroğlu OA; Telli Dizman G; Özışık L; Şahin TK; Taş Z; İnkaya AÇ; Karahan S; Alp Ş; Alp A; Metan G; Zarakol P; Sain Güven G; Öz ŞG; Topeli A; Uzun Ö; Akova M; Ünal S
Turk J Med Sci; 2021 Apr; 51(2):411-420. PubMed ID: 32718127
[TBL] [Abstract][Full Text] [Related]
3. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
4. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
Cavalcanti AB; Zampieri FG; Rosa RG; Azevedo LCP; Veiga VC; Avezum A; Damiani LP; Marcadenti A; Kawano-Dourado L; Lisboa T; Junqueira DLM; de Barros E Silva PGM; Tramujas L; Abreu-Silva EO; Laranjeira LN; Soares AT; Echenique LS; Pereira AJ; Freitas FGR; Gebara OCE; Dantas VCS; Furtado RHM; Milan EP; Golin NA; Cardoso FF; Maia IS; Hoffmann Filho CR; Kormann APM; Amazonas RB; Bocchi de Oliveira MF; Serpa-Neto A; Falavigna M; Lopes RD; Machado FR; Berwanger O;
N Engl J Med; 2020 Nov; 383(21):2041-2052. PubMed ID: 32706953
[TBL] [Abstract][Full Text] [Related]
5. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients.
Carlucci PM; Ahuja T; Petrilli C; Rajagopalan H; Jones S; Rahimian J
J Med Microbiol; 2020 Oct; 69(10):1228-1234. PubMed ID: 32930657
[No Abstract] [Full Text] [Related]
6. Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir.
Rahmani H; Davoudi-Monfared E; Nourian A; Nabiee M; Sadeghi S; Khalili H; Abbasian L; Ghiasvand F; Seifi A; Hasannezhad M; Ghaderkhani S; Mohammadi M; Yekaninejad MS
Daru; 2020 Dec; 28(2):625-634. PubMed ID: 32857301
[TBL] [Abstract][Full Text] [Related]
7. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine use in hospitalised patients with COVID-19: An observational matched cohort study.
Kalligeros M; Shehadeh F; Atalla E; Mylona EK; Aung S; Pandita A; Larkin J; Sanchez M; Touzard-Romo F; Brotherton A; Shah R; Cunha CB; Mylonakis E
J Glob Antimicrob Resist; 2020 Sep; 22():842-844. PubMed ID: 32763357
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
Lagier JC; Million M; Gautret P; Colson P; Cortaredona S; Giraud-Gatineau A; Honoré S; Gaubert JY; Fournier PE; Tissot-Dupont H; Chabrière E; Stein A; Deharo JC; Fenollar F; Rolain JM; Obadia Y; Jacquier A; La Scola B; Brouqui P; Drancourt M; Parola P; Raoult D;
Travel Med Infect Dis; 2020; 36():101791. PubMed ID: 32593867
[TBL] [Abstract][Full Text] [Related]
10. Early experimental COVID-19 therapies: associations with length of hospital stay, mortality and related costs.
Vernaz N; Agoritsas T; Calmy A; Gayet-Ageron A; Gold G; Perrier A; Picard F; Prendki V; Reny JL; Samer C; Stirnemann J; Vetter P; Zanella MC; Zekry D; Baggio S
Swiss Med Wkly; 2020 Dec; 150():w20446. PubMed ID: 33382449
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Evidence Accelerator: A parallel analysis to describe the use of Hydroxychloroquine with or without Azithromycin among hospitalized COVID-19 patients.
Stewart M; Rodriguez-Watson C; Albayrak A; Asubonteng J; Belli A; Brown T; Cho K; Das R; Eldridge E; Gatto N; Gelman A; Gerlovin H; Goldberg SL; Hansen E; Hirsch J; Ho YL; Ip A; Izano M; Jones J; Justice AC; Klesh R; Kuranz S; Lam C; Mao Q; Mataraso S; Mera R; Posner DC; Rassen JA; Siefkas A; Schrag A; Tourassi G; Weckstein A; Wolf F; Bhat A; Winckler S; Sigal EV; Allen J
PLoS One; 2021; 16(3):e0248128. PubMed ID: 33730088
[TBL] [Abstract][Full Text] [Related]
12. Combination of Hydroxychloroquine Plus Azithromycin As Potential Treatment for COVID-19 Patients: Safety Profile, Drug Interactions, and Management of Toxicity.
Hache G; Rolain JM; Gautret P; Deharo JC; Brouqui P; Raoult D; Honoré S
Microb Drug Resist; 2021 Mar; 27(3):281-290. PubMed ID: 33729874
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive strategy for the early treatment of COVID-19 with azithromycin/hydroxychloroquine and/or corticosteroids: Results of a retrospective observational study in the French overseas department of Réunion Island.
Dubernet A; Larsen K; Masse L; Allyn J; Foch E; Bruneau L; Maillot A; Lagrange-Xelot M; Thomas V; Jaffar-Bandjee MC; Gauzere L; Raffray L; Borsu K; Dibernardo S; Renaud S; André M; Moreau D; Jabot J; Coolen-Allou N; Allou N
J Glob Antimicrob Resist; 2020 Dec; 23():1-3. PubMed ID: 32828896
[TBL] [Abstract][Full Text] [Related]
14. Real-Life Data on Hydroxychloroquine or Chloroquine with or Without Azithromycin in COVID-19 Patients: A Retrospective Analysis in Brazil.
Souza-Silva MVR; Pereira DN; Pires MC; Vasconcelos IM; Schwarzbold AV; Vasconcelos DH; Pereira EC; Manenti ERF; Costa FR; Aguiar FC; Anschau F; Bartolazzi F; Nascimento GF; Vianna HR; Batista JDL; Machado-Rugolo J; Ruschel KB; Ferreira MAP; Oliveira LS; Menezes LSM; Ziegelmann PK; Tofani MGT; Bicalho MAC; Nogueira MCA; Guimarães-Júnior MH; Aguiar RLO; Rios DRA; Polanczyk CA; Marcolino MS
Arq Bras Cardiol; 2023 Sep; 120(9):e20220935. PubMed ID: 37878893
[TBL] [Abstract][Full Text] [Related]
15. Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
Mori N; Katayama M; Nukaga S
J Microbiol Immunol Infect; 2021 Feb; 54(1):109-112. PubMed ID: 33054978
[TBL] [Abstract][Full Text] [Related]
16. Pharmacoepidemiology, Machine Learning, and COVID-19: An Intent-to-Treat Analysis of Hydroxychloroquine, With or Without Azithromycin, and COVID-19 Outcomes Among Hospitalized US Veterans.
Gerlovin H; Posner DC; Ho YL; Rentsch CT; Tate JP; King JT; Kurgansky KE; Danciu I; Costa L; Linares FA; Goethert ID; Jacobson DA; Freiberg MS; Begoli E; Muralidhar S; Ramoni RB; Tourassi G; Gaziano JM; Justice AC; Gagnon DR; Cho K
Am J Epidemiol; 2021 Nov; 190(11):2405-2419. PubMed ID: 34165150
[TBL] [Abstract][Full Text] [Related]
17. Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: authors' response.
Fiolet T; Guihur A; Rebeaud ME; Mulot M; Peiffer-Smadja N; Mahamat-Saleh Y
Clin Microbiol Infect; 2021 Jan; 27(1):138-140. PubMed ID: 33080383
[No Abstract] [Full Text] [Related]
18. Effectiveness of Streptococcus Pneumoniae Urinary Antigen Testing in Decreasing Mortality of COVID-19 Co-Infected Patients: A Clinical Investigation.
Desai A; Santonocito OG; Caltagirone G; Kogan M; Ghetti F; Donadoni I; Porro F; Savevski V; Poretti D; Ciccarelli M; Martinelli Boneschi F; Voza A
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33138045
[TBL] [Abstract][Full Text] [Related]
19. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
Furtado RHM; Berwanger O; Fonseca HA; Corrêa TD; Ferraz LR; Lapa MG; Zampieri FG; Veiga VC; Azevedo LCP; Rosa RG; Lopes RD; Avezum A; Manoel ALO; Piza FMT; Martins PA; Lisboa TC; Pereira AJ; Olivato GB; Dantas VCS; Milan EP; Gebara OCE; Amazonas RB; Oliveira MB; Soares RVP; Moia DDF; Piano LPA; Castilho K; Momesso RGRAP; Schettino GPP; Rizzo LV; Neto AS; Machado FR; Cavalcanti AB;
Lancet; 2020 Oct; 396(10256):959-967. PubMed ID: 32896292
[TBL] [Abstract][Full Text] [Related]
20. Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
Sivapalan P; Ulrik CS; Lappere TS; Eklöf JV; Shaker SB; Bødtger UCS; Browatzki A; Meyer CN; Weinreich UM; Laursen CB; Biering-Sørensen T; Knop FK; Lundgren JD; Jensen JS
Trials; 2020 Oct; 21(1):867. PubMed ID: 33081817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]